ANGPTL3 (angiopoietin-like protein 3) is a circulating protein with a key role in maintaining lipoprotein homeostasis. A monoclonal antibody against ANGPTL3 is an approved and well-tolerated treatment to reduce lipoproteins in familial hypercholesterolemia homozygotes. However, the reduction of hepatic ANGPTL3 synthesis using an antisense oligonucleotide unexpectedly resulted in a dose-dependent increase in liver lipid content and circulating transaminases, resulting in the termination of the clinical trial. Meanwhile, the use of silencing RNAs remains an area of active investigation. Our study sought to investigate whether intracellular downregulation of ANGPTL3 may lead to a primary increase in neutral lipids within the hepatocyte.

Pennisi, G., Maurotti, S., Ciociola, E., Jamialahmadi, O., Bertolazzi, G., Mirarchi, A., et al. (2024). ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY [10.1161/atvbaha.123.319789].

ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization

Pennisi, Grazia
Primo
;
Bertolazzi, Giorgio;Tripodo, Claudio;Petta, Salvatore
Penultimo
;
2024-02-22

Abstract

ANGPTL3 (angiopoietin-like protein 3) is a circulating protein with a key role in maintaining lipoprotein homeostasis. A monoclonal antibody against ANGPTL3 is an approved and well-tolerated treatment to reduce lipoproteins in familial hypercholesterolemia homozygotes. However, the reduction of hepatic ANGPTL3 synthesis using an antisense oligonucleotide unexpectedly resulted in a dose-dependent increase in liver lipid content and circulating transaminases, resulting in the termination of the clinical trial. Meanwhile, the use of silencing RNAs remains an area of active investigation. Our study sought to investigate whether intracellular downregulation of ANGPTL3 may lead to a primary increase in neutral lipids within the hepatocyte.
22-feb-2024
Pennisi, G., Maurotti, S., Ciociola, E., Jamialahmadi, O., Bertolazzi, G., Mirarchi, A., et al. (2024). ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY [10.1161/atvbaha.123.319789].
File in questo prodotto:
File Dimensione Formato  
Pennisi_et_al.pdf

Solo gestori archvio

Descrizione: articolo completo
Tipologia: Versione Editoriale
Dimensione 1.84 MB
Formato Adobe PDF
1.84 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/631257
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact